Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer

被引:187
作者
Madalinska, JB
Hollenstein, J
Bleiker, E
van Beurden, M
Valdimarsdottir, HB
Massuger, LF
Gaarenstroom, KN
Mourits, MJE
Verheijen, RHM
van Dorst, EBL
van der Putten, H
van der Velden, K
Boonstra, H
Aaronson, NK
机构
[1] Netherlands Canc Inst, Dept Gynecol, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Gynaecol, Amsterdam, Netherlands
[3] Acad Med Ctr, Dept Gynecol, Amsterdam, Netherlands
[4] Univ Nijmegen, Med Ctr, Dept Gynecol, Nijmegen, Netherlands
[5] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol, Groningen, Netherlands
[7] Univ Utrecht, Med Ctr, Dept Gynecol, Utrecht, Netherlands
[8] Acad Hosp Maastricht, Dept Gynecol, Maastricht, Netherlands
[9] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
关键词
D O I
10.1200/JCO.2005.02.626
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: Recommendations for women at high risk of ovarian cancer include periodic gynecologic screening (GS) and prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to determine the quality-of-life (QOL) effects of PBSO versus GS. Patients and Methods: Questionnaire data were obtained from 846 high-risk women who had participated in this nationwide, cross-sectional, observational study. Forty-four percent of the women had undergone PBSO, and 56% had opted for GS. Topics addressed by the questionnaire included generic QOL, cancer-specific distress, endocrine symptoms, and sexual functioning. Results: No statistically significant between-group differences were observed in generic QOL (Short Form-36), with women in both the PBSO and GS groups scoring similarly to the general population. Compared with GS, PBSO was associated with fewer breast and ovarian cancer worries (P < .001) and more favorable cancer risk perception (P < .05). However, the PBSO group reported significantly more endocrine symptoms (P < .001) and worse sexual functioning (P < .05) than the GS group. Eighty-six percent of women would choose PBSO again, and 63% would recommend it to a friend with familial risk of ovarian cancer. Conclusion: PBSO had no measurable adverse impact on generic QOL of high-risk women. The favorable effects of PBSO in terms of reduced cancer worries and low perceived cancer risk need to be weighed against the increase in endocrine and sexual symptoms. Balanced information will help clinicians and high-risk women to make informed decisions about the optimal preventive health strategy. © 2005 by American Society of Clinical Oncology.
引用
收藏
页码:6890 / 6898
页数:9
相关论文
共 44 条
[1]
Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations [J].
Aaronson, NK ;
Muller, M ;
Cohen, PDA ;
Essink-Bot, ML ;
Fekkes, M ;
Sanderman, R ;
Sprangers, MAG ;
Velde, AT ;
Verrips, E .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (11) :1055-1068
[2]
THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[3]
[Anonymous], 1985, Nederlands Tijdschrift Voor de Psychologie
[4]
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies [J].
Antoniou, A ;
Pharoah, PDP ;
Narod, S ;
Risch, HA ;
Eyfjord, JE ;
Hopper, JL ;
Loman, N ;
Olsson, H ;
Johannsson, O ;
Borg, Å ;
Pasini, B ;
Radice, P ;
Manoukian, S ;
Eccles, DM ;
Tang, N ;
Olah, E ;
Anton-Culver, H ;
Warner, E ;
Lubinski, J ;
Gronwald, J ;
Gorski, B ;
Tulinius, H ;
Thorlacius, S ;
Eerola, H ;
Nevanlinna, H ;
Syrjäkoski, K ;
Kallioniemi, OP ;
Thompson, D ;
Evans, C ;
Peto, J ;
Lalloo, F ;
Evans, DG ;
Easton, DF .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1117-1130
[5]
Vasomotor flushes in menopausal women [J].
Bachmann, GA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (03) :S312-S316
[6]
The performance of screening tests for ovarian cancer: results of a systematic review [J].
Bell, R ;
Petticrew, M ;
Sheldon, T .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (11) :1136-1147
[7]
Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO
[8]
2-Z
[9]
Cohen J., 1988, STAT POWER ANAL BEHA
[10]
Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer [J].
Elit L. ;
Esplen M.J. ;
Butler K. ;
Narod S. .
Familial Cancer, 2001, 1 (3-4) :149-156